|
|
|
|
||
|
||
|
Vol. 8, Nos. 1-50, pp. 1-1650 Jan. 1 -- Dec. 31, 2010 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Kammerer, U.S. ex rel. v. Omnicare Inc. (N.D. Ill.), 1213
Kappos; Arius Two Inc. v. (D.D.C.), 233 Kappos; Bilski v. (U.S.), 847 Kappos; Idera Pharms. Inc. v. (D.D.C.), 202 Kappos; Medicines Co. v. (E.D. Va.), 154; 350; 713; 1050 Kappos; Novartis AG v. (D.D.C.), 917 Kappos; PhotoCure ASA v. (Fed. Cir.), 617 Kappos; Wyeth v. (Fed. Cir.), 57 Karkoska v. Johnson & Johnson (D. Minn.), 1021 K-Dur Antitrust Litig., In re (D.N.J.), 411; 519 Kellogg v. Wyeth (D. Vt.), 1467 Kendall v. Hoffmann-LaRoche Inc. (N.J. Super. Ct.), 1055 Kester v. Zimmer Holdings Inc. (W.D. Pa.), 1366 Kieff, U.S. ex rel. v. Wyeth (D. Mass.), 646 King v. Baldino (3d Cir.), 1622 King v. Bayer Pharms. Corp. (W.D. La.), 556 King, U.S. ex rel. v. Solvay S.A. (S.D. Tex.), 982 King Drug Co. of Florence Inc. v. Cephalon Inc. (E.D. Pa.), 412 King Pharms. Inc. v. CorePharma LLC (D.N.J.), 641 King Pharms. Inc. v. Eon Labs Inc. (Fed. Cir.), 1014; (E.D.N.Y.), 1276 King Pharms. Inc.; Purdue Pharma LP v. (D.N.J.), 239 King Pharms. Inc. v. Sandoz Inc. (D.N.J.), 641; 676 Kirk, U.S. ex rel.; Schindler Elevator Corp. v. (U.S., brief filed), 1551 Koch v. I-Flow Corp. (D.R.I.), 783 Koor v. Merck & Co. (S.D.N.Y.), 624 Kooshian; U.S. v. (C.D. Cal.), 240 Kos Pharms.; U.S. v. (M.D. La.), 1550 Kramer v. Allergan Inc. (Cal. Super. Ct.), 322 Kresler; U.S. v. (11th Cir.), 1107 KV Pharm. Co.; Lefaivre v. (E.D. Mo.), 66 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
